On January 9, 2013 scientists from the U.S. Centers for Disease Control and Prevention co-authored a JAMA editorial along with partners titled “Cephalosporin-Resistant Gonorrhea in North America.” The editorial sounds the alarm on the potential threat of drug resistant gonorrhea, outlines updated gonorrhea treatment guidelines, and encourage the development of new drugs to treat the common sexually transmitted infection.
In the editorial, authors note that “the antibiotic pipeline is running dry: continued investment in antibiotic development is critical. Meanwhile, the gonococcus has continued to develop the capability to defeat each new antibiotic used. The threat of drug-resistant gonorrhea is increasing and has reached North America. Clinicians, drug developers, and public health professionals must act now.”
The full editorial can be read online at